Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Eliprodil in Parkinson's Disease
NCT00001929Phase 2Completed
- Sponsor
- National Institute of Neurological Disorders and Stroke
- Start
- Mar 1999
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of eliprodil in Parkinson's disease (PD), sponsored by National Institute of Neurological Disorders and Stroke. Started Mar 1999; status: completed.
02
Drugs
eliprodil
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT00001929.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00001929.